AmLexin™ is a patented, natural joint-care ingredient containing Morus alba and Acacia catechu. It has demonstrated the ability to help protect cartilage integrity.
Key Pointers
AmLexin™ 400mg was significantly better at reducing uCTX-II, a type II collagen degradation biomarker, when compared to a combination of Glucosamine 1500mg + Chondroitin 1200mg
Helps protect joints from natural wear and tear, by neutralizing superoxide anion
Clinically proven to support exercise recovery and reduce delayed onset of muscular soreness (DOMS)
Effectively inhibits cartilage catabolic pathways by modulating COX-1, COX-2 and 5-LOX enzyme activity
Key Pointers
AmLexin™ 400mg was significantly better at reducing uCTX-II, a type II collagen degradation biomarker, when compared to a combination of Glucosamine 1500mg + Chondroitin 1200mg
Helps protect joints from natural wear and tear, by neutralizing superoxide anion
Clinically proven to support exercise recovery and reduce delayed onset of muscular soreness (DOMS)
Effectively inhibits cartilage catabolic pathways by modulating COX-1, COX-2 and 5-LOX enzyme activity
Clinical Findings
In a clinical study on subjects with knee osteoarthritis, AmLexin™ at 400mg is clinically proven to reduce cartilage degradation significantly better than Glucosamine 1500mg and Chondroitin 1200mg
Proven significantly better at reducing uCTX-II, a type II collagen degradation biomarker by 8.9%
Proven to support exercise recovery and reduce delayed onset of muscular soreness (DOMS) in a second clinical trial, on subjects performing strenous sport activity
AmLexin™ has been shown to be effective in an ex vivo GAG assay, at reducing Glycosaminoglycan (GAG) released by articular cartilage
